- Feb 23, 2018 Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of Acute Graft-versus-Host Disease
- Feb 13, 2018 Jazz Pharmaceuticals to Report 2017 Fourth Quarter and Full Year Financial Results on February 27, 2018
- Feb 08, 2018 National Comprehensive Cancer Network® adds Jazz Pharmaceuticals' Vyxeos™ (daunorubicin and cytarabine) Liposome for Injection to Clinical Practice Guidelines in Oncology
- Jan 02, 2018 Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 8
Data provided by Nasdaq. Minimum 15 minutes delayed.